353 related articles for article (PubMed ID: 30867839)
21. Dental and Cranial Pathologies in Mice Lacking the Cl(-) /H(+) -Exchanger ClC-7.
Wen X; Lacruz RS; Paine ML
Anat Rec (Hoboken); 2015 Aug; 298(8):1502-8. PubMed ID: 25663454
[TBL] [Abstract][Full Text] [Related]
22. The Cl- transporter ClC-7 is essential for phagocytic clearance by microglia.
Iyer H; Talbot WS
J Cell Sci; 2024 Feb; 137(4):. PubMed ID: 38294065
[TBL] [Abstract][Full Text] [Related]
23. A Case of Autosomal Dominant Osteopetrosis Type 2 with a
Kang S; Kang YK; Lee JA; Kim DH; Lim JS
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):439-443. PubMed ID: 30759959
[TBL] [Abstract][Full Text] [Related]
24. Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC-7 Mutants.
Di Zanni E; Palagano E; Lagostena L; Strina D; Rehman A; Abinun M; De Somer L; Martire B; Brown J; Kariminejad A; Balasubramaniam S; Baynam G; Gurrieri F; Pisanti MA; De Maggio I; Abboud MR; Chiesa R; Burren CP; Villa A; Sobacchi C; Picollo A
J Bone Miner Res; 2021 Mar; 36(3):531-545. PubMed ID: 33125761
[TBL] [Abstract][Full Text] [Related]
25. Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology.
Coudert AE; Del Fattore A; Baulard C; Olaso R; Schiltz C; Collet C; Teti A; de Vernejoul MC
Lab Invest; 2014 Mar; 94(3):275-85. PubMed ID: 24336069
[TBL] [Abstract][Full Text] [Related]
26. Identification of two novel mutations on CLCN7 gene in a patient with malignant ostopetrosis.
Bonapace G; Moricca MT; Talarico V; Graziano F; Pensabene L; Miniero R
Ital J Pediatr; 2014 Nov; 40():90. PubMed ID: 25410126
[TBL] [Abstract][Full Text] [Related]
27. A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene.
Hofstaetter JG; Atkins GJ; Kato H; Kogawa M; Blouin S; Misof BM; Roschger P; Evdokiou A; Yang D; Solomon LB; Findlay DM; Ito N
Calcif Tissue Int; 2022 Oct; 111(4):430-444. PubMed ID: 35618777
[TBL] [Abstract][Full Text] [Related]
28. Novel mutations in Indian patients with autosomal recessive infantile malignant osteopetrosis.
Phadke SR; Fischer B; Gupta N; Ranganath P; Kabra M; Kornak U
Indian J Med Res; 2010 Apr; 131():508-14. PubMed ID: 20424301
[TBL] [Abstract][Full Text] [Related]
29. A novel CLCN7 mutation resulting in a most severe form of autosomal recessive osteopetrosis.
Besbas N; Draaken M; Ludwig M; Deren O; Orhan D; Bilginer Y; Ozaltin F
Eur J Pediatr; 2009 Dec; 168(12):1449-54. PubMed ID: 19238435
[TBL] [Abstract][Full Text] [Related]
30. Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl
Bose S; de Heus C; Kennedy ME; Wang F; Jentsch TJ; Klumperman J; Stauber T
Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136669
[TBL] [Abstract][Full Text] [Related]
31. Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.
Capulli M; Maurizi A; Ventura L; Rucci N; Teti A
Mol Ther Nucleic Acids; 2015 Sep; 4(9):e248. PubMed ID: 26325626
[TBL] [Abstract][Full Text] [Related]
32. Osteopetrosis and related osteoclast disorders in adults: A review and knowledge gaps On behalf of the European calcified tissue society and ERN BOND.
Funck-Brentano T; Zillikens MC; Clunie G; Siggelkow H; Appelman-Dijkstra NM; Cohen-Solal M
Eur J Med Genet; 2024 Jun; 69():104936. PubMed ID: 38593953
[TBL] [Abstract][Full Text] [Related]
33. A newly described mutation of the CLCN7 gene causes neuropathic autosomal recessive osteopetrosis in an Arab family.
Al-Aama JY; Dabbagh AA; Edrees AY
Clin Dysmorphol; 2012 Jan; 21(1):1-7. PubMed ID: 21946807
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II.
Kornak U; Ostertag A; Branger S; Benichou O; de Vernejoul MC
J Clin Endocrinol Metab; 2006 Mar; 91(3):995-1000. PubMed ID: 16368748
[TBL] [Abstract][Full Text] [Related]
35.
Sun X; Zhang R; Chen H; Du X; Chen S; Huang J; Liu M; Xu M; Luo F; Jin M; Su N; Qi H; Yang J; Tan Q; Zhang D; Ni Z; Liang S; Zhang B; Chen D; Zhang X; Luo L; Chen L; Xie Y
Theranostics; 2020; 10(16):7111-7130. PubMed ID: 32641982
[TBL] [Abstract][Full Text] [Related]
36. Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.
Cleiren E; Bénichou O; Van Hul E; Gram J; Bollerslev J; Singer FR; Beaverson K; Aledo A; Whyte MP; Yoneyama T; deVernejoul MC; Van Hul W
Hum Mol Genet; 2001 Dec; 10(25):2861-7. PubMed ID: 11741829
[TBL] [Abstract][Full Text] [Related]
37. The Role of the Lysosomal Cl
Zifarelli G
Cells; 2022 Jan; 11(3):. PubMed ID: 35159175
[TBL] [Abstract][Full Text] [Related]
38. Autosomal dominant osteopetrosis associated with renal tubular acidosis is due to a CLCN7 mutation.
Piret SE; Gorvin CM; Trinh A; Taylor J; Lise S; Taylor JC; Ebeling PR; Thakker RV
Am J Med Genet A; 2016 Nov; 170(11):2988-2992. PubMed ID: 27540713
[TBL] [Abstract][Full Text] [Related]
39. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.
Waguespack SG; Hui SL; Dimeglio LA; Econs MJ
J Clin Endocrinol Metab; 2007 Mar; 92(3):771-8. PubMed ID: 17164308
[TBL] [Abstract][Full Text] [Related]
40. Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis.
Campos-Xavier AB; Saraiva JM; Ribeiro LM; Munnich A; Cormier-Daire V
Hum Genet; 2003 Feb; 112(2):186-9. PubMed ID: 12522560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
